Moody National Bank Trust Division Edwards Lifesciences Corp Transaction History

Moody National Bank Trust Division

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	SELL	$69.28 - $93.38 $4,156 - $5,602	-60 Reduced 0.92%	6,473 $448,000
Q2 2022 Jul 07, 2022	BUY	$86.5 - $128.27 $565,104 - $837,987	6,533 New	6,533 $621,000
Q2 2019 Jul 22, 2019	SELL	$55.74 - $64.41 $9,698 - $11,207	-174 Closed	0 $0
Q1 2019 Apr 11, 2019	BUY	$47.89 - $64.05 $1,340 - $1,793	28 Added 19.18%	174 $33,000
Q4 2018 Jan 07, 2019	BUY	$46.41 - $56.94 $6,775 - $8,313	146 New	146 $22,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

Stay updated on Moody National Bank Trust Division with notifications on news.